Altogether, when administering GLP-1RA plus SGLT2i combination therapy, it is important to adopt an individualized approach to therapy taking into account individual preferences, costs and coverage, toxicity profile, consideration of kidney function and glucose-lowering efficacy, desire for weight loss, and comorbidities
That unforeseen outcome stimulated randomized, double-blind clinical trials in which semaglutide helped participants lose as much as fifteen kilograms over sixteen months
Women navigating menopause while on GLP-1 therapy face a dual challenge, as hormonal changes independently promote weight gain
But this isnt just about the number on the scale, its about where the weight goes
These days, its nearly impossible to avoid chatter about GLP-1s